Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Nuclear Medicine

Free Subscription 18.09.2023 36 Clin Nucl Med 5 J Nucl Med 11 Nucl Med Commun 2 Nuklearmedizin 1 Phys Med Biol 1 PLoS One 1 Synapse

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin Nucl Med

1. BASSO DIAS A, Ghai S, Ortega C, Mirshahvalad SA, et al
   Impact of 18F-DCFPyL PET/MRI in Selecting Men With Low-/Intermediate-Risk Prostate Cancer for Focal Ablative Therapies.
   Clin Nucl Med. 2023;48:e462-e467.
   PubMed         Abstract available
   
   
2. NDUM F, Seifert P, Freesmeyer M, Guhne F, et al
   Noninvasive Verification of a Very Small Intraocular Prostate Carcinoma Metastasis by 68Ga-PSMA-11 PET/CT.
   Clin Nucl Med. 2023;48:915-916.
   PubMed         Abstract available
   
   
3. ZHAO Q, Dong A, Zuo C
   68Ga-PSMA-11 PET/CT in a Case of Isolated Parietal Peritoneal Metastasis From Prostate Adenocarcinoma.
   Clin Nucl Med. 2023;48:913-914.
   PubMed         Abstract available
   
   
4. CHEN T, Li W, Fan J
   A Case of Primary Esophageal Sarcomatoid Carcinoma Detected by 18F-FDG PET/CT.
   Clin Nucl Med. 2023;48:910-912.
   PubMed         Abstract available
   
   
5. ZHAO Q, Dong A, Zuo C, Chen H, et al
   FDG-Avid Malakoplakia of the Ureter Mimicking Malignancy.
   Clin Nucl Med. 2023;48:907-909.
   PubMed         Abstract available
   
   
6. YANG P, Xiao L, Li L
   Primary Angiosarcoma of Lumbar Pedicle and Transverse Process Revealed by FDG PET/CT.
   Clin Nucl Med. 2023;48:905-906.
   PubMed         Abstract available
   
   
7. JI X, Dong A, Wang Y
   FDG PET/CT in Follicular Dendritic Cell Sarcoma of the Jejunum With Hepatic Metastasis.
   Clin Nucl Med. 2023;48:902-904.
   PubMed         Abstract available
   
   
8. WANG H, Deng Y, He L, Deng Y, et al
   Renal Interstitial Fibrosis Detected on 18F-AlF-NOTA-FAPI-04 PET/CT in a Patient With Multiple Myeloma.
   Clin Nucl Med. 2023;48:896-898.
   PubMed         Abstract available
   
   
9. CHO E, Park CH, Kim J, Kim K, et al
   Serial 68Ga-FAPI PET/CT After Treatment of Immunoglobulin G4-Related Pancreatitis and Retroperitoneal Fibrosis.
   Clin Nucl Med. 2023;48:883-887.
   PubMed         Abstract available
   
   
10. KIM YS, Park DG, Shin IJ, An YS, et al
    Striatal Hyperperfusion Observed in Dual-Phase 18F-FP-CIT PET Imaging of Hyperglycemic Chorea.
    Clin Nucl Med. 2023;48:881-882.
    PubMed         Abstract available
    
    
11. SOYDAS-TURAN B, Tuncel M
    Unexpected Axillary Lymph Node Uptake During Lower-Limb Lymphoscintigraphy in a Case With Vulvar Lymphangioma Circumscriptum.
    Clin Nucl Med. 2023;48:879-880.
    PubMed         Abstract available
    
    
12. ZANG J, Lin R, Wen X, Wang C, et al
    A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
    Clin Nucl Med. 2023;48:861-868.
    PubMed         Abstract available
    
    
13. WATABE T, Ose N, Naka S, Fukui E, et al
    Evaluation of LAT1 Expression in Patients With Lung Cancer and Mediastinal Tumors: 18F-FBPA PET Study With Immunohistological Comparison.
    Clin Nucl Med. 2023;48:853-860.
    PubMed         Abstract available
    
    
14. KUNTE SC, Schwarting SK, Holzgreve A, Wohrle C, et al
    Divergent Findings in the Diagnosis of ATTR-CM Using Common Cardiac Diagnostics and 99m Tc-DPD Scintigraphy.
    Clin Nucl Med. 2023;48:888-889.
    PubMed         Abstract available
    
    
15. BRONTE VIEDMA A, Bastidas Tamayo JF, Rosales Castillo JJ, Campo Ezquibela A, et al
    Asthma as an Inflammatory Reason of Tracheobronchial PSMA Uptake.
    Clin Nucl Med. 2023;48:e494-e495.
    PubMed         Abstract available
    
    
16. MAHALIK A, Chaudhary B, Kumar R, Tripathi M, et al
    18 F-FES Uptake in Radiation Pneumonitis.
    Clin Nucl Med. 2023;48:e468-e469.
    PubMed         Abstract available
    
    
17. PAN Q, Zhang H, Cao X, Li J, et al
    Langerhans Cell Histiocytosis Showed Intense Uptake of 68 Ga-FAPI.
    Clin Nucl Med. 2023;48:894-895.
    PubMed         Abstract available
    
    
18. ALCIN G, Arslan E, Baykara Ulusan M, Aksoy T, et al
    68 Ga-DOTA-FAPI-04 Imaging of Bilateral Phyllodes Tumor.
    Clin Nucl Med. 2023;48:e480-e482.
    PubMed         Abstract available
    
    
19. TAKAMATSU A, Yoshida K, Watanabe S, Komori T, et al
    Comparison of 18F-FDG PET Findings of Pegfilgrastim-Induced Aortitis With Other Types of Large-Vessel Vasculitis: A Retrospective Observational Study.
    Clin Nucl Med. 2023 Sep 13. doi: 10.1097/RLU.0000000000004847.
    PubMed         Abstract available
    
    
20. PANG Y, Cai J, Zhao L, Xu W, et al
    Superior Identification of Metastatic Lesions by 68Ga-FAPI-46 to 18F-FDG PET/CT in a Case of SMARCA4-Deficient Undifferentiated Carcinoma of Stomach.
    Clin Nucl Med. 2023 Sep 13. doi: 10.1097/RLU.0000000000004860.
    PubMed         Abstract available
    
    
21. LIU M, Zhou J, Zhu W, Huo L, et al
    Mesenteric Castleman Disease Misdiagnosed as Lymph Node Metastasis of Rectal Cancer on 18F-FDG PET/CT.
    Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004832.
    PubMed         Abstract available
    
    
22. METSER U, Ezzat S, Singh S, Myrehaug S, et al
    68Ga-DOTATATE PET/CT in the Initial Diagnosis of Patients With Clinical, Imaging, and/or Biochemical Suspicion of a Neuroendocrine Tumor.
    Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004829.
    PubMed         Abstract available
    
    
23. LEWIS MC, Wale DJ, Liao E, Viglianti BL, et al
    Incidental Uptake in a Subacute Stroke on 18F-Piflufolastat PSMA PET/CT.
    Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004798.
    PubMed         Abstract available
    
    
24. USMANI S, Jain A, Akhter SMJ, Al Riyami K, et al
    18F-FDG PET/CT Imaging of Pulmonary Hamartomas: Metabolic and Functional Characterization.
    Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004842.
    PubMed         Abstract available
    
    
25. TAO Z, Qiu Y, Huang W, Wang A, et al
    Small Cell Carcinoma of the Ureter With Early Recurrence and Multiple Metastases Shown on 18F-FDG PET/CT.
    Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004828.
    PubMed         Abstract available
    
    
26. LIU M, Liu H, Chen X, Zhang S, et al
    Pulmonary Cryptococcosis: Intense Uptake on Both 18F-FDG and 68Ga-FAPI PET/CT.
    Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004864.
    PubMed         Abstract available
    
    
27. DENG Y, Deng Y, Wang H, Xie H, et al
    Solitary Axillary Lymph Node Metastasis From Bladder Cancer Detected by FDG PET/CT.
    Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004827.
    PubMed         Abstract available
    
    
28. LIANG M, Niu N, Jia C, Fan S, et al
    Diagnostic Superiority of 18F-FDG PET Over MRI in Detecting Anti-LGI1 Autoimmune Encephalitis: A Comparative Study With Insights Into Faciobrachial Dystonic Seizures Mechanisms and Recurrence Identification.
    Clin Nucl Med. 2023 Sep 8. doi: 10.1097/RLU.0000000000004862.
    PubMed         Abstract available
    
    
29. MU X, Li M, Huang J, Wang Z, et al
    Fibroblast Activation Protein-Targeted PET/CT Imaging in a Treatment-Naive Prostate Cancer Patient With Low PSMA Expression.
    Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004825.
    PubMed         Abstract available
    
    
30. CHEN H, Dai J, Gao F, Tian R, et al
    Right Adrenocortical Carcinoma Coexisting With Left Adrenal Sarcomatoid Carcinoma on FDG PET/CT.
    Clin Nucl Med. 2023;48:e503-e505.
    PubMed         Abstract available
    
    
31. SKYUM SM, Anthonsen AK, Salkus G, Kvon D, et al
    Intravenous Pyogenic Granuloma in the Inguinal Canal Mimicking Lymph Node Metastasis on PSMA PET/CT.
    Clin Nucl Med. 2023;48:e500-e502.
    PubMed         Abstract available
    
    
32. ZHAO X, Long Z, Yu L, Wang X, et al
    18F-FDG PET/CT in a Patient With Epididymo-Testicular Malacoplakia.
    Clin Nucl Med. 2023;48:e496-e499.
    PubMed         Abstract available
    
    
33. HATANO K, Ishibashi K, Yamada K, Ishii K, et al
    Clinical Application of 18F-THK5351 PET to Identify Inflammatory Lesions Through Imaging Astrogliosis in a Case of Cytomegalovirus Ventriculoencephalitis.
    Clin Nucl Med. 2023;48:e489-e490.
    PubMed         Abstract available
    
    
34. KESIM S, Dede F, Cesmecioglu E, Karaman D, et al
    Bone Lipogranuloma Mimicking Metastatic Disease on 18F-FDG PET/CT.
    Clin Nucl Med. 2023;48:e485-e486.
    PubMed         Abstract available
    
    
35. LIN Q, Wang Y, Zhao W, Yao S, et al
    Visualization of Thromboinflammation by 18F-DPA-714 PET in a Stroke Patient.
    Clin Nucl Med. 2023;48:e477-e479.
    PubMed         Abstract available
    
    
36. ZHANG J, Jiang S, Zhang R, Zhang L, et al
    Increased 18F-FAPI Uptake in Radiation-Induced Liver Injury.
    Clin Nucl Med. 2023;48:e474-e476.
    PubMed         Abstract available
    
    

    
    J Nucl Med

37. GOGOLA A, Lopresti BJ, Tudorascu D, Snitz B, et al
    Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies.
    J Nucl Med. 2023 Sep 14:jnumed.123.265941. doi: 10.2967/jnumed.123.265941.
    PubMed        
    
    
38. GEORGOULIAS P, Angelidis G, Koukouraki S, Koutsikos J, et al
    Debating the Future of Nuclear Medicine: The Greek Experience.
    J Nucl Med. 2023 Sep 14:jnumed.123.266646. doi: 10.2967/jnumed.123.266646.
    PubMed        
    
    
39. SEBAN RD
    Reply to: HER2-Low Breast Cancer Can Be Visualized by HER2 PET.
    J Nucl Med. 2023 Sep 14:jnumed.123.266490. doi: 10.2967/jnumed.123.266490.
    PubMed        
    
    
40. ALTENA R, Af Buren S, Tran T, Axelsson R, et al
    HER2-Low Breast Cancer Can Be Visualized by HER2 PET.
    J Nucl Med. 2023 Sep 14:jnumed.123.266101. doi: 10.2967/jnumed.123.266101.
    PubMed        
    
    
41. ROGASCH JMM, Metzger G, Preisler M, Galler M, et al
    ChatGPT: Can You Prepare My Patients for [(18)F]FDG PET/CT and Explain My Reports?
    J Nucl Med. 2023 Sep 14:jnumed.123.266114. doi: 10.2967/jnumed.123.266114.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

42. MISSIR E, Begley P, Jessop M, Singh N, et al
    Quantitative [123]I-Ioflupane DaTSCAN single-photon computed tomography-computed tomography in Parkinsonism.
    Nucl Med Commun. 2023;44:843-853.
    PubMed         Abstract available
    
    
43. GHAEDIAN T, Abdinejad M, Nasrollahi H, Ghaedian M, et al
    Comparing the role of 99m Tc-HYNIC-PSMA-11 and 99m Tc-MDP scintigraphy for the initial staging of intermediate to high-risk prostate cancer.
    Nucl Med Commun. 2023;44:864-869.
    PubMed         Abstract available
    
    
44. AKTAS A, Baskin E, Gencoglu EA, Colak T, et al
    Comparison of parathyroid scintigraphy findings in pediatric and adult patients with secondary hyperparathyroidism.
    Nucl Med Commun. 2023;44:860-863.
    PubMed         Abstract available
    
    
45. HAIDAR M, Jazra D, Kassas M
    Challenging false positive findings in 68Ga-FAPI PET: insights from a clinical case.
    Nucl Med Commun. 2023;44:924-926.
    PubMed        
    
    
46. MCCREADY R, Dizdarevic S
    Acronyms in Nuclear Medicine (AINM).
    Nucl Med Commun. 2023;44:926.
    PubMed        
    
    
47. IRWIN AG
    Scientific support for nuclear medicine.
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001754.
    PubMed         Abstract available
    
    
48. GHOSH S, Agrawal A, Rangarajan V, Choudhury S, et al
    Evaluation of post-chemotherapy residual seminomatous masses by 18F-fluorodeoxyglucose PET/CT using tumor-to-liver ratio - conundrum or solution?
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001762.
    PubMed         Abstract available
    
    
49. HAIDAR M, Kassas M, Chehade F, Chahinian R, et al
    The role of 18F-FDG-PET/CT in the management of differentiated thyroid cancer.
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001758.
    PubMed         Abstract available
    
    
50. WANG H, Xie X, Duan Y, Chai L, et al
    Rabbit systemic glucose metabolism map by total-body dynamic PET/CT technology.
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001767.
    PubMed         Abstract available
    
    
51. WAMASING N, Nakamura S, Watanabe H, Kuribayashi A, et al
    Potential of preoperative fluorodeoxyglucose-positron emission tomography/computed tomography to diagnose contralateral lymph node metastases in patients with oral cancer.
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001765.
    PubMed         Abstract available
    
    
52. BIN ESSA N, Kaplar Z, Balaji N, Alduraibi A, et al
    PET/CT in treatment response assessment in lung cancer. When should it be recommended?
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001757.
    PubMed         Abstract available
    
    

    
    Nuklearmedizin

53. DEININGER K, Raacke JN, Yousefzadeh-Nowshahr E, Kropf-Sanchen C, et al
    Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLC.
    Nuklearmedizin. 2023 Sep 11. doi: 10.1055/a-2150-4130.
    PubMed         Abstract available
    
    
54. MIEDERER I, Rogasch JMM, Fischer R, Fuchs T, et al
    The Medical Informatics Initiative and the Network University Medicine - Perspectives for Nuclear Medicine.
    Nuklearmedizin. 2023 Sep 8. doi: 10.1055/a-2067-7642.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

55. REYMANN MP, Vija AH, Maier A
    Method for comparison of data driven gating algorithms in emission tomography.
    Phys Med Biol. 2023;68.
    PubMed         Abstract available
    
    

    
    PLoS One

56. BULUT G, Atilgan HI, Cinarer G, Kilic K, et al
    Prediction of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer by using a deep learning model with 18F-FDG PET/CT.
    PLoS One. 2023;18:e0290543.
    PubMed         Abstract available
    
    

    
    Synapse

57. THOMSEN MB, Landau AM, Bender D, Cumming P, et al
    Autoradiographic characterization of [(18) F]PSMA-1007 binding in rat brain.
    Synapse. 2023;77:e22280.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: